Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Gabapentin Enacarbil Immediate Release

Aliases
Gabapentin Enacarbil Immediate Release (GE-IR) 200 mg, Gabapentin Enacarbil Immediate Release (GE-IR) 450 mg, Gabapentin Enacarbil Immediate Release (GE-IR) 700 mg, Horizant
Name
Gabapentin
INN Name
gabapentin enacarbil
FDA Approved
Yes

1 clinical trial

7 organizations

1 indication

3 documents

Indication
Abuse Potential
Clinical trial
A Randomized, Double Blind, Active and Placebo Controlled, 5 Way Crossover Study to Determine the Abuse Potential of Orally Administered Gabapentin Enacarbil Immediate Release Capsules in Healthy, Nondependent Recreational Drug Users With Sedative Experience
Status: Completed, Estimated PCD: 2022-06-30
Organization
Physicians Total Care, Inc.
Document
DailyMed Label: Gabapentin
Organization
Contract Pharmacy Services-PA
Organization
Blenheim Pharmacal, Inc.
Organization
STAT RX USA LLC
Document
DailyMed Label: Horizant
Organization
Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
Document
DailyMed Label: GABAPENTIN
Organization
Aphena Pharma Solutions - Tennessee, LLC
Organization
EXELAN PHARMACEUTICALS INC.